Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pituitary Neoplasms × pegvisomant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Acromegaly 1

Interventions

pasireotide 4 Cabergoline 3 pegvisomant 1 farletuzumab 1 TBR-760 1 Octreotide 1 90Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Novartis

Phase 4 Completed

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡